Search

Your search keyword '"Stilgenbauer, Stephan"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Stilgenbauer, Stephan" Remove constraint Author: "Stilgenbauer, Stephan" Database OpenAIRE Remove constraint Database: OpenAIRE
110 results on '"Stilgenbauer, Stephan"'

Search Results

1. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis

2. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

3. Combined burden and functional impact tests for cancer driver discovery using DriverPower

4. Integrative pathway enrichment analysis of multivariate omics data

5. Pathway and network analysis of more than 2500 whole cancer genomes

6. Divergent mutational processes distinguish hypoxic and normoxic tumours

7. Genomic footprints of activated telomere maintenance mechanisms in cancer

9. High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without TP53 Aberrations Treated with Venetoclax-Based Time-Limited Combinations

10. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape

11. Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study

12. The genomic and transcriptional landscape of primary central nervous system lymphoma

14. Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell Lymphoma

15. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

16. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients

17. Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia : Primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)

21. Additional file 1 of Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019

23. Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)

24. Longitudinal CT Imaging to Explore the Predictive Power of 3D Radiomic Tumour Heterogeneity in Precise Imaging of Mantle Cell Lymphoma (MCL)

25. The landscape of genomic alterations across childhood cancers

26. IGLV3-21*01 is an inherited risk factor for CLL throughthe acquisition of a single-point mutation enablingautonomous BCR signaling

27. Leitlinie - ICD10: C91.60 / C91.61 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

28. Additional file 11 of Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

29. Additional file 1 of Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

30. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie h��matologischer und onkologischer Erkrankungen

31. TBET‐expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice

32. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

33. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance

34. IG-MYC1 neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

35. Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials

36. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

37. IG‐MYC ‐positive leukemia and lymphoma with precursor B‐cell phenotype are genetically and epigenetically distinct from Burkitt lymphomas

38. The landscape of genomic alterations across childhood cancers

39. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib

40. The European Hematology Association Roadmap for European Hematology Research: a consensus document

41. Lamin B1 regulates somatic mutation and progression of B cell malignancies

42. Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy

43. Leitlinie - ICD10: C91.60 / C91.61 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

46. Alterations of miRNAs and miRNA-regulated mRNA expression in GC B cell lymphomas determined by integrative sequencing analysis

48. Additional file 3: Figure S2. of Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model

49. Additional file 2: Figure S1. of Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model

50. Additional file 4: Figure S3. of Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model

Catalog

Books, media, physical & digital resources